市場調查報告書
商品編碼
1182182
猴痘檢測全球市場規模研究與預測,按技術(聚合□鏈反應(PCR)、側流分析(LFA)等),用戶(醫院/診所、診斷實驗室等)區域分析2022-2029Global Monkeypox Testing Market Size study & Forecast, by Technology (Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Others), by End-User (Hospitals and Clinics, Diagnostic Laboratories, Others) and Regional Analysis, 2022-2029 |
2021 年全球猴痘檢測市場價值約為 179 萬美元,預計在 2022-2029 年預測期內將以超過 4.35% 的健康增長率增長。
猴痘是一種病毒性人畜共患疾病,其症狀與天花相似,通常包括皮疹、淋巴結腫大、發燒和各種並發症。 猴痘通過與受感染的個人或動物密切接觸,或通過接觸被病毒污染的材料傳播給人類。 猴痘檢測是一種用於診斷疾病、檢測病情、規劃治療、治療能力或隨時間監測病情的程序。 公眾意識的提高以及政府支持和舉措的增加正在推動全球市場的增長。
世界範圍內猴痘負擔的增加增加了檢測的必要性,以便及時獲得治療並避免潛在的嚴重情況。 根據美國疾病控制與預防中心的數據,截至 2022 年 9 月 27 日,全球已報告 66,551 例病例,其中 26 人死亡。 與其他地區相比,美國和歐洲的註冊患者人數估計最多。 因此,目標疾病的流行率不斷上升,對猴痘檢測產生了巨大的利潤豐厚的需求。 此外,由於診斷研究的進步和研發活動資金的增加,預測期內各種增長前景都很突出。 然而,根除疫情的困難和與研發活動相關的高成本阻礙了整個 2022-2029 年預測期內的市場增長。
全球猴痘檢測市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於猴痘發病率上升和各種成熟市場參與者的存在,北美在收入方面佔據了市場主導地位。 另一方面,預計歐洲在預測期內將呈現顯著的增長率。 政府支持的增加、病毒的高發病率和流行率以及對擴大該地區檢測能力的日益關注等因素推動了預測期內的市場增長。
本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模,並預測未來幾年的市場規模。 該報告旨在包括被調查國家工業的定性和定量方面。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和產品供應的深入分析。
Global Monkeypox Testing Market is valued at approximately USD 1.79 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.35% over the forecast period 2022-2029. Monkeypox is a viral zoonotic disease that is similar symptoms to smallpox, which generally includes rash and swollen lymph nodes, fever, and a variety of medical complications. Monkeypox is spread in humans through close contact with a diseased individual or animal, or with material that is contaminated with the virus. Monkeypox testing is a procedure for the diagnosis of disease and detecting a condition, planning treatment, treatment competence, or monitoring the condition over time. The growing awareness among the population and increasing government support and initiatives are driving market growth across the globe.
The rising burden of monkeypox around the world is propelling the need for testing to receive treatment on time and evade the chances of a serious condition. According to the Centers for Disease Control and Prevention, on 27th September 2022, 66,551 cases were reported with 26 deaths around the world. The United States and Europe are estimated to have the highest number of registered cases compared to other regions. Thereby, the rising prevalence of the target disease is creating a lucrative demand for monkeypox testing at a substantial rate. Moreover, the rising advancements in diagnosis research, as well as growing funding for research and development activities are offering various growth prospects in the forecasting years. However, difficulty in determining the cause of the spread and high costs related to the R&D activities are hindering market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Monkeypox Testing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising incidence of monkeypox and the presence of various well-established market players. Whereas, Europe is expected to grow at a significant growth rate during the forecast period. Factors such as rising government support, the highest occurrence and spread of the virus, as well as growing focus on expanding testing capacities in the region are burgeoning the market growth in the forecasting years.
Major market players included in this report are:
Aegis Sciences Corporation
Laboratory Corp. of America Holdings
Quest Diagnostics, Inc.
Sonic Healthcare Ltd.
QIAGEN
Mayo Clinic Laboratories
Chembio Diagnostics, Inc.
Sonora Quest Laboratories
Thermo Fisher Scientific
Becton, Dickinson, and Company
Recent Developments in the Market:
Global Monkeypox Testing Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Technology, End-User, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.
The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-User:
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable